浙江交科(002061.SZ):預中標10.25億元杭州彭埠互通改建工程施工項目
格隆匯12月25日丨浙江交科(002061.SZ)發佈公告,近日,公司收到下屬公司浙江交工集團股份有限公司(以下簡稱“浙江交工”)發來的通知,浙江交工參與杭州彭埠互通改建工程第TJ01標段施工投標,2019年12月25日,招標人公示了評標結果,浙江交工確認為中標候選人。擬中標金額人民幣102,521.5255萬元。
公告表示,預中標項目符合公司主營業務戰略佈局,能夠鞏固公司長三角地區市場競爭力和市場佔有率,若上述中標項目順利實施將對公司業績將產生積極影響。該項目尚處於公示期,最終能否取得《中標通知書》並簽署合同尚存在不確定性。公司將根據項目後續進展,及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.